Skip to main content
Fig. 4 | BMC Biotechnology

Fig. 4

From: Impacts of loading thymoquinone to gold or silver nanoparticles on the efficacy of anti-tumor treatments in breast cancer with or without chemotherapeutic cisplatin

Fig. 4

In vivo anti-tumor activity of AuNPs or AuNPs composites on EAC tumor-bearing mice. EAC tumor-bearing mice received PBS, CP, TQ, AuNPs, AgNPs AuNPs/TQ, ANPs/TQ, AuNPs/TQ + CP, or ANPs/TQ + CP daily for 6 successive days. The euthanasia of the mice occurred on the eleventh day subsequent to the inoculation of tumor cells. EAC cells were collected to assess their viability through the trypan blue method. Data are stated as mean ± SE (n = 5). A statistically significant difference between the groups was established at P < 0.05. a, b,c indicate statistically significant differences when compared to the EAC tumor-bearing mice receiving PBS (a), EAC tumor-bearing mice receiving CP (b), EAC tumor-bearing receiving TQ (c)

Back to article page

BMC Biotechnology

ISSN: 1472-6750

Contact us